BRAIN Biotech AG

Supplier
Summarized by Halo AI

BRAIN Biotech AG is an industrial biotechnology group specializing in the development and production of specialty enzymes, proteins, and microbial strains to enable sustainable industrial processes for the food, health, and life science sectors.

Company size
Less than 500 employees
Revenue
~EUR 49.6M (2024)
Portfolio summary
Specialty enzymes, microorganisms, bioactive natural products, and customized biological solutions for sustainable industrial processes, along with contract research services and R&D incubator projects
Markets served
EMEA · NA
Manufacturing locations
The company operates four manufacturing sites under Biocatalysts located in Cardiff (United Kingdom), Nieuwkuijk (Netherlands), Büttelborn (Germany, whose production is migrating to Nieuwkuijk), and Tampa (United States)
R&D locations
Zwingenberg, Germany · Potsdam, Germany

BRAIN Biotech AG is an integrated industrial biotechnology company that develops, produces, and distributes specialty enzymes, proteins, and microbial production strains. The company operates through two main business segments: BRAINBiocatalysts, which focuses on the commercialization of enzymes and specialty ingredients, and BRAINBioIncubator, which conducts research-intensive development projects. Utilizing advanced expertise in biology, bioinformatics, and bioprocess engineering, the company provides end-to-end services ranging from discovery and strain development to large-scale fermentation and manufacturing. They function as a partner for industries including food and beverage, life sciences, and chemical sectors, delivering solutions that aim to enhance industrial sustainability and efficiency.

By leveraging their proprietary technology portfolio and R&D capabilities, BRAIN Biotech enables customers to optimize production processes and develop more sustainable bio-based products. With over 30 years of experience, the company serves as an innovation partner that helps clients navigate complex development challenges, from laboratory-scale concepts to commercial-scale production. Their work directly addresses global sustainability goals by providing biological alternatives for traditional industrial methods. The group operates international facilities across Europe and the USA, providing a robust infrastructure to support long-term development partnerships and the monetization of biotechnological intellectual property.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

KR
Katja Riedel
Principal Investigator
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Co-developmentSupply/purchaseLicensing

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.